The FDA is expected to issue new guidance on biosimilars labeling and generic opioids before the end of year, according to a report by the Regulatory Affairs Professional Society.
The CDC’s Advisory Committee on Immunization Practices made a unanimous recommendation for use of meningococcal group B vaccines to vaccinate high-risk groups in the United States.
Sanofi expands its portfolio of insulin therapy products with the introduction of the once-daily, long-acting Toujeo.
The fixed-combination drug Avycaz was granted priority review by the Food and Drug Administration.
The National Association of Chain Drug Stores has submitted a statement to the U.S. House Committee on Energy and Commerce Subcommittee on Health expressing concerns about pharmacy-related budget proposals.
The Food and Drug Administration is looking into enabling holders of abbreviated new drug applications to unilaterally update their generic drug product labels prior to any branded drug change.
Lupin will bring to market a generic version of Lumigan solution, the company announced.
NPA renewed its call to the New York Attorney General to produce the scientific evidence behind that office's recall request of herbal supplements.
Kim Coalter, a staffer for Rep. Thad Cochran, R-Miss., toured Fred's Super Dollar pharmacy in Mississippi last week.
The recently introduced Ensuring Patient Access and Effective Drug Enforcement Act of 2015 receives support from the National Association of Chain Drug Stores.